Update of Antimicrobial Resistance in Level III and IV Health Institutions in Colombia Between January 2018 and December 2021

Overview

Journal Biomedica

Specialty General Medicine

Date 2023 Dec 18

PMID 38109138

Authors

Elsa De la Cadena

Christian Jose Pallares

Juan Carlos Garcia-Betancur

Jessica A Porras

Maria Virginia Villegas

Affiliations

Soon will be listed here.

Abstract

Introduction: Antimicrobial resistance surveillance is a fundamental tool for the development, improvement, and adjustment of antimicrobial stewardship programs, therapeutic guidelines, and universal precautions to limit the cross-transmission of resistant bacteria between patients. Since the beginning of 2020, the SARS-CoV-2 pandemic profoundly challenged the health system and, according to some reports, increased the rates of antimicrobial resistance.

Objective: To describe the behavior of antimicrobial resistance of the most frequent bacterial pathogens in twenty Colombian hospitals from January 2018 to December 2021.

Materials And Methods: We conducted a descriptive study based on the microbiological information recorded from January 2018 to December 2021 in twenty levels III and IV health institutions in twelve Colombian cities. We identified the species of the ten most frequent bacteria along with their resistance profile to the antibiotic markers after analyzing the data through WHONET.

Results: We found no statistically significant changes in most pathogens’ resistance profiles from January 2018 to December 2021. Only Pseudomonas aeruginosa had a statistically significant increase in its resistance profile, particularly to piperacillin/tazobactam and carbapenems.

Conclusions: The changes in antimicrobial resistance in these four years were not statistically significant except for P. aeruginosa to piperacillin/tazobactam and carbapenems.

Citing Articles

[Nine-year trend in Escherichia coli resistance to ciprofloxacin: cross-sectional study in a hospital in Colombia].

Villalobos E, Ossa J, Meza Y, Gulloso A Cad Saude Publica. 2024; 40(7):e00031723.

PMID: 39194094 PMC: 11349281. DOI: 10.1590/0102-311XES031723.

References

Paterson D, Rossi F, Baquero F, Hsueh P, Woods G, Satishchandran V . In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother. 2005; 55(6):965-73. DOI: 10.1093/jac/dki117. View

Rawson T, Ming D, Ahmad R, Moore L, Holmes A . Antimicrobial use, drug-resistant infections and COVID-19. Nat Rev Microbiol. 2020; 18(8):409-410. PMC: 7264971. DOI: 10.1038/s41579-020-0395-y. View

Fournier P, Richet H . The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis. 2006; 42(5):692-9. DOI: 10.1086/500202. View

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

Critchley I, Karlowsky J . Optimal use of antibiotic resistance surveillance systems. Clin Microbiol Infect. 2004; 10(6):502-11. DOI: 10.1111/j.1469-0691.2004.00911.x. View

Ovalle M, Saavedra S, Gonzalez M, Hidalgo A, Duarte C, Beltran M . Results of the national surveillance of antimicrobial resistance of Enterobacteriaceae and Gram negative bacilli in health care-associated infections in Colombia, 2012-2014. Biomedica. 2018; 37(4):473-485. DOI: 10.7705/biomedica.v37i4.3432. View

Segala F, Bavaro D, Di Gennaro F, Salvati F, Marotta C, Saracino A . Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review. Viruses. 2021; 13(11). PMC: 8624326. DOI: 10.3390/v13112110. View

Maes M, Higginson E, Pereira-Dias J, Curran M, Parmar S, Khokhar F . Ventilator-associated pneumonia in critically ill patients with COVID-19. Crit Care. 2021; 25(1):25. PMC: 7797892. DOI: 10.1186/s13054-021-03460-5. View

Russo A, Gavaruzzi F, Ceccarelli G, Borrazzo C, Oliva A, Alessandri F . Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection. 2021; 50(1):83-92. PMC: 8236000. DOI: 10.1007/s15010-021-01643-4. View

10.

Patel A, Emerick M, Cabunoc M, Williams M, Preas M, Schrank G . Rapid Spread and Control of Multidrug-Resistant Gram-Negative Bacteria in COVID-19 Patient Care Units. Emerg Infect Dis. 2021; 27(4):1234-1237. PMC: 8007317. DOI: 10.3201/eid2704.204036. View

11.

Plante J, Mitchell B, Plante K, Debbink K, Weaver S, Menachery V . The variant gambit: COVID-19's next move. Cell Host Microbe. 2021; 29(4):508-515. PMC: 7919536. DOI: 10.1016/j.chom.2021.02.020. View

12.

Stelling J, OBrien T . Surveillance of antimicrobial resistance: the WHONET program. Clin Infect Dis. 1997; 24 Suppl 1:S157-68. DOI: 10.1093/clinids/24.supplement_1.s157. View

13.

Haustein T, Gastmeier P, Holmes A, Lucet J, Shannon R, Pittet D . Use of benchmarking and public reporting for infection control in four high-income countries. Lancet Infect Dis. 2011; 11(6):471-81. DOI: 10.1016/S1473-3099(10)70315-7. View

14.

Martinez-Guerra B, Gonzalez-Lara M, de-Leon-Cividanes N, Tamez-Torres K, Roman-Montes C, Rajme-Lopez S . Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic. Antibiotics (Basel). 2021; 10(2). PMC: 7917840. DOI: 10.3390/antibiotics10020182. View

15.

Rawson T, Moore L, Castro-Sanchez E, Charani E, Davies F, Satta G . COVID-19 and the potential long-term impact on antimicrobial resistance. J Antimicrob Chemother. 2020; 75(7):1681-1684. PMC: 7314000. DOI: 10.1093/jac/dkaa194. View

16.

van Duin D, Barlow G, Nathwani D . The impact of the COVID-19 pandemic on antimicrobial resistance: a debate. JAC Antimicrob Resist. 2021; 2(3):dlaa053. PMC: 7454677. DOI: 10.1093/jacamr/dlaa053. View

17.

Khojasteh S, Jafarzdeh J, Hosseini S, Haghani I, Turki H, Gharehbolagh S . and COVID-19: A health threatening combination. Curr Med Mycol. 2023; 8(3):44-50. PMC: 10084486. DOI: 10.18502/cmm.8.3.11211. View

18.

Briceno D, Correa A, Valencia C, Torres J, Pacheco R, Montealegre M . [Antimicrobial resistance of Gram negative bacilli isolated from tertiary-care hospitals in Colombia]. Biomedica. 2011; 30(3):371-81. View

19.

Kariyawasam R, Julien D, Jelinski D, Larose S, Rennert-May E, Conly J . Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021). Antimicrob Resist Infect Control. 2022; 11(1):45. PMC: 8899460. DOI: 10.1186/s13756-022-01085-z. View

20.

Bork J, Leekha S, Claeys K, Seung H, Tripoli M, Amoroso A . Change in hospital antibiotic use and acquisition of multidrug-resistant gram-negative organisms after the onset of coronavirus disease 2019. Infect Control Hosp Epidemiol. 2020; 42(9):1115-1117. PMC: 7783138. DOI: 10.1017/ice.2020.1360. View